From October 1, 2023 to December 31, 2023, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 121,500 shares, representing 1.17% for $0.05 million under the buyback announced on October 9, 2019.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.38 USD | +2.99% | -10.39% | +140.00% |
05-31 | Sector Update: Health Care Stocks Advance Friday Afternoon | MT |
05-31 | Ocugen Gets Recommendation For Dose Escalation in Eye Disease Trial; Shares Climb | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+140.00% | 355M | |
+34.01% | 51.07B | |
+34.55% | 38.61B | |
-8.02% | 38.78B | |
-8.98% | 27.32B | |
+12.56% | 26.35B | |
-19.62% | 19.46B | |
+39.18% | 13.58B | |
+31.47% | 12.46B | |
-3.40% | 11.75B |
- Stock Market
- Equities
- OCGN Stock
- News Ocugen, Inc.
- Tranche Update on Ocugen, Inc.'s Equity Buyback Plan announced on October 9, 2019.